Delaware’s innovation pipeline could be at risk with new NIH funding policy
With a proposed cap on indirect costs for NIH grants, Delaware's life science sector could be hit the next generation of start-ups. The post 🔒 Delaware’s innovation pipeline could be at risk with new NIH funding policy appeared first on Delaware Business Times.